Trademarkia Logo

Canada

C$
EMPRELVIA
REGISTERED

on 22 Apr 2020

Last Applicant/ Owned by

CORBUS PHARMACEUTICALS INC.

500 River Ridge Drive, Second FloorNorwood, MA 02062

US

Serial Number

1849060 filed on 21st Jul 2017

Registration Number

TMA1077137 registered on 22nd Apr 2020

Registration expiry Date

22nd Apr 2030

Correspondent Address

BORDEN LADNER GERVAIS LLP

ATTN: INTELLECTUAL PROPERTY DEPARTMENT1000 DE LA GAUCHETIERE STREET WESTSUITE 900MONTREAL

QUEBEC

CA

H3B5H4

EMPRELVIA

Trademark usage description

pharmaceutical products for the treatment of fibrosis and inflammatory diseases, namely, cystic fibrosis, systemic sclerosis, dermatomyositis, and sys Read More

Classification Information


Class [005]
Pharmaceutical products for the treatment of fibrosis and inflammatory diseases, namely, cystic fibrosis, systemic sclerosis, dermatomyositis, and systemic lupus erythematosus.


Classification kind code

11

Mark Details


Serial Number

1849060

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 190
on 18th Sept 2019
Registration Pending
Submitted for opposition 42
on 26th Jun 2019
Advertised
Submitted for opposition 26
on 6th Jun 2019
Approved
Submitted for opposition 135
on 23rd May 2019
Amendment to Application
Submitted for opposition 27
on 16th Apr 2019
Approval Notice Sent
Submitted for opposition 22
on 11th Jul 2018
Search Recorded
Submitted for opposition 20
on 11th Jul 2018
Examiner's First Report
Submitted for opposition 31
on 27th Jul 2017
Formalized
Submitted for opposition 1
on 25th Jul 2017
Created
Submitted for opposition 30
on 21st Jul 2017
Filed